Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigation
Nicola Relitti(University of Siena), Giuseppe Campiani(University of Siena), Stefania Butini(University of Siena), Manfred Jung(University of Freiburg), Cristina Ulivieri(University of Siena), Giovina Ruberti(National Research Council), Federica Sarno(University of Campania "Luigi Vanvitelli"), Stefania Lamponi(University of Siena), Lucia Altucci(Biogem), Giulia Chemi(University of Siena), Fulvio Saccoccia(National Research Council), Simone Brogi(University of Pisa), Daniel Herp(University of Freiburg), Margherita Brindisi(University of Naples Federico II), A. Prasanth Saraswati(University of Siena), Sandra Gemma(University of Siena), Francesca Vanni(University of Siena)
Cited by 43
Related Papers
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery
|Cell|2016|570
Apoptotic cell death in disease—Current understanding of the NCCD 2023
|Cell Death and Differentiation|2023|371
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Selective Sirt2 inhibition by ligand-induced rearrangement of the active site
|Nature Communications|2015|297